Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 17/20 | 0.79 |
| ▸ | HDAC3 | O15379 | 15/20 | 0.79 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.60 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20176396 | 0.89 | HDAC2 (1.00) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 | |
| SCHEMBL20176386 | 0.83 | HDAC2 (0.81) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 | |
| SCHEMBL20181484 | 0.80 | HDAC2 (1.00) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 | |
| SCHEMBL20181511 | 0.79 | KCNH2 (1.00) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 | |
| SCHEMBL20181653 | 0.75 | HDAC2 (1.00) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 | |
| SCHEMBL20181469 | 0.75 | HDAC2 (1.00) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 | |
| SCHEMBL5224561 | 0.73 | HDAC2 (0.76) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 | |
| SCHEMBL20181493 | 0.73 | HDAC2 (1.00) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 | |
| SCHEMBL20181846 | 0.73 | KCNH2 (0.82) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 | |
| SCHEMBL21275920 | 0.73 | HDAC2 (0.55) | HDAC2HDAC3KCNH2CYP1A2CYP2C18 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180141923-A1 | SELECTIVE HDAC1,2 INHIBITORS | REGENACY PHARMACEUTICALS, LLC | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141923-A1 | SELECTIVE HDAC1,2 INHIBITORS | HDAC1, HDAC2, HDAC11 | HDAC2 2/4885HDAC3 6/4885KCNH2 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.